You are here: Industry Insights > formulations

News List

Brief Description of the Application of Hot Melt Extrusion in Pharmaceutical Formulations PharmaSources/Shaluo
April 18, 2022
Hot Melt Extrusion (HME), also known as Melt Extrusion technique, refers to a technology in which drugs and carrier excipients are uniformly mixed in a molten state and extruded with a certain pressure, speed and shape.
NPPA fixes retail prices for 14 formulations expresspharma
July 03, 2020
The fixed formulations are used to treat diabetes, hypertension, cholesterol, women’s health and mental health disorders.
NPPA revises ceiling price of scheduled formulations expresspharma
April 07, 2020
In compliance of the provisions of Drugs (Price Control) Order 2013, the NPPA has revised/ increased the ceiling price of 883 scheduled formulations.
DGFT allows pharma cos to continue export of 13 APIs/ formulations from SEZ units expresspharma
March 23, 2020
The Directorate General of Foreign Trade (DGFT), an arm of the Ministry of Commerce and Industry clarified the earlier issued notification ...
Exports of certain APIs, formulations put under restricted category expresspharma
March 04, 2020
Exports of certain APIs and formulations, including Paracetamol, Vitamin B1 and B12, have been put under restricted category amid the coronavirus outbreak in China, according to a government notification.
After APIs, Carcinogens NDMA and NDEA Now Impacting Formulations PharmaSources/Dishui Sinan
February 03, 2020
NMPA (CDE) released on its website the Technical Guidelines for the Research of Nitrosamine Impurities in Chemical Drugs (Draft for Comment) on Jan. 10, 2020.
FDA Grants Fast Track to Amplyx for IV and Oral Formulations of Fosmanogepix americanpharmaceuticalreview
September 10, 2019
Amplyx Pharmaceuticals announced the U.S. Food & Drug Administration (FDA) has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antifungal candidate...
Natco plans to launch 8-10 branded formulations this year expressbpd
June 07, 2017
Natco Pharma plans to launch around 8-10 new products in domestic branded formulations segment during the current year as it aims to grow over 20 per cent year-on-year during the period.